West Pharmaceutical Services Tax on Share Settlement increased by 1150.0% to $2.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $2.50M to $2.50M. Over 4 years (FY 2021 to FY 2025), Tax on Share Settlement shows a downward trend with a -34.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Increases generally correlate with higher levels of stock-based compensation and the timing of equity award vesting cycles.
Cash payments made by the company to tax authorities on behalf of employees to cover withholding taxes triggered by the...
Commonly reported by technology companies with significant stock-based compensation programs.
taxes_paid_for_shares| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $700.00K | $300.00K | $100.00K | $18.80M | $300.00K | $300.00K | $0.00 | $11.50M | $1.00M | $300.00K | $100.00K | $5.40M | $100.00K | $0.00 | $200.00K | $2.50M | $0.00 | $100.00K | $200.00K | $2.50M |
| QoQ Change | — | -57.1% | -66.7% | >999% | -98.4% | +0.0% | -100.0% | — | -91.3% | -70.0% | -66.7% | >999% | -98.1% | -100.0% | — | >999% | -100.0% | — | +100.0% | >999% |
| YoY Change | — | — | — | — | -57.1% | +0.0% | -100.0% | -38.8% | +233.3% | +0.0% | — | -53.0% | -90.0% | -100.0% | +100.0% | -53.7% | -100.0% | — | +0.0% | +0.0% |